Palantir on Thursday is hosting AIPCon 4, the company's AI event focused on showcasing how customers are successfully deploying Palantir's Artificial Intelligence Platform (AIP) in their businesses.
Replimune reported that the IGNYTE clinical trial of RP1 plus nivolumab in anti-PD1 failed melanoma showed a 33.6% response rate, with all responses lasting over six months. The treatment was well-tolerated.
The FDA's advisory committee will review Eli Lilly's Phase 3 study on donanemab for Alzheimer's disease on June 10. This review assesses the drug's benefit-risk profile based on significant efficacy results in cognition and daily function.
GameStop shares surged in early May after Keith Gill, also known as "Roaring Kitty" made his return to social media following three years of silence. Gill is often credited with spearheading the meme stock movement of 2021 that saw multiple heavily shorted stocks squeeze higher as retail traders piled into the names.